Return
Exploring new treatment strategies for hard-to-treat double-hit and double-expressor lymphomas
M
R
DOI:10.1080/1750743X.2025.2572956.png)
Abstract
En 中文
Double-hit (DHL) and double-expressor (DEL) large B-cell lymphomas (LBCL) are relatively rare, with the former occurring in 5–12% of LBCL and the latter in up to a third [1]. Despite this, their as...
Keywords:
Lymphoma
double-hit
double-expressor
DLBCL
cellular therapy
CAR-T
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
J
IF:
2.9
Papers:
2.1K
Citations:
3.2K
